study to see the clinical subtypes and management of carcinoma esophagus
Not Applicable
- Conditions
- Health Condition 1: C158- Malignant neoplasm of overlappingsites of esophagus
- Registration Number
- CTRI/2023/05/052500
- Lead Sponsor
- ASHWIN OOMMEN PHILIPS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ALL BIOPSY PROVEN CARCINOMA ESOPHAGUS PATIENTS MANAGED AT THE HOSPITAL OVER THE LAST 5 YEARS
Exclusion Criteria
NO BIOPSY REPORTS
TREATED OUTSIDE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CLINICAL PROFILE , OVERALL SURVIVAL AND PROGRESSION FREE SURVIVALTimepoint: 12months, 24 months, 36months, 48 months, 60 months
- Secondary Outcome Measures
Name Time Method PROGRESSION FREE SURVIVAL AND OVERALL SURVIVALTimepoint: 12months, 24 months, 36months, 48 months, 60 months